States / Texas / SB 1525

SB 1525 Passed First Chamber

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
May 8, 2025 · House
Read first time
May 8, 2025 · House
Referred to Insurance
May 7, 2025 · Senate
Rules suspended-Regular order of business
May 7, 2025 · Senate
Vote recorded in Journal
May 7, 2025 · Senate
Read 2nd time & passed to engrossment
May 7, 2025 · Senate
Vote recorded in Journal
May 7, 2025 · Senate
Three day rule suspended
May 7, 2025 · Senate
Record vote
May 7, 2025 · Senate
Read 3rd time
May 7, 2025 · Senate
Passed
May 7, 2025 · Senate
Record vote
May 7, 2025 · Senate
Reported engrossed
May 7, 2025 · House
Received from the Senate
May 7, 2025 · Senate
Co-author authorized
May 6, 2025 · Senate
Placed on intent calendar
May 5, 2025 · Senate
Recommended for local & uncontested calendar
May 5, 2025 · Senate
Committee report printed and distributed
May 5, 2025 · Senate
Reported favorably as substituted
Apr 30, 2025 · Senate
Considered in public hearing
Apr 30, 2025 · Senate
Vote taken in committee
Apr 23, 2025 · Senate
Scheduled for public hearing on . . .
Apr 23, 2025 · Senate
Considered in public hearing
Apr 23, 2025 · Senate
Testimony taken in committee
Apr 23, 2025 · Senate
Left pending in committee
Mar 6, 2025 · Senate
Read first time
Mar 6, 2025 · Senate
Referred to Health & Human Services
Feb 21, 2025 · Senate
Received by the Secretary of the Senate
Feb 21, 2025 · Senate
Filed